Advertisement
Canada markets open in 9 hours 25 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7325
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    83.81
    +0.24 (+0.29%)
     

  • Bitcoin CAD

    87,885.23
    +52.84 (+0.06%)
     

  • CMC Crypto 200

    1,390.28
    +7.71 (+0.56%)
     

  • GOLD FUTURES

    2,346.40
    +3.90 (+0.17%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,767.75
    +200.25 (+1.14%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,931.94
    +303.46 (+0.81%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Five Star Equities Issues New Research Reports on ADM, IDIX, KMX and SPRD

ACCESSWIRE

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Archer Daniels Midland Company (NYSE:ADM - News) shares increased 1.47 percent to close at $33.09 a share Friday. The stock traded between $32.77 and $33.49 on volume of 6.27 million shares traded. The company announced that is in discussions regarding the potential sale of ADM cocoa. Shares of Archer Daniels Midland have gained approximately 20.8 percent year-to-date.

Get more information on Archer Daniels Midland and free access to the in-depth equity report at:
www.FiveStarEquities.com/ADM

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX - News) shares plunged 30.70 percent to close at $3.56 a share Friday. The stock traded between $3.35 and $3.75 on volume of 8.59 million shares traded. The company announced that the FDA has requested additional preclinical safety information for IDX20963 before it can proceed with clinical trials. Shares of Idenix Pharmaceuticals have fallen approximately 26.7 percent year-to-date.

ADVERTISEMENT

Get more information on Idenix Pharmaceuticals and free access to the in-depth equity report at:
www.FiveStarEquities.com/IDIX

CarMax, Inc. (NYSE:KMX - News) shares hit a high of $48.10 before settling to close at $44.59 a share. The stock traded between $42.21 and $48.10 on volume of 8.56 million shares traded. The company reported net earnings of $146.7 million for the first quarter of 2013, an increase of 21 percent when compared to the year ago quarter. Shares of CarMax have gained approximately 18.8 percent year-to-date.

Get more information on CarMax and free access to the in-depth equity report at:
www.FiveStarEquities.com/KMX

Spreadtrum Communications, Inc. (NASDAQ:SPRD - News) shares spiked 16.24 percent to close at $25.91 a share Friday. The stock traded between $25.33 and $26.69 on volume of 6.15 million shares traded. The company announced that it has received a non-binding offer acquisition offer from Tsinghua Unigroup Ltd. of $28.50 per American depositary share, a premium of approximately 28 percent to Thursday’s closing price. Shares of Spreadtrum Communications have gained approximately 47.0 percent year-to-date.

Get more information on Spreadtrum Communications and free access to the in-depth equity report at:
www.FiveStarEquities.com/SPRD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com